Status:
COMPLETED
Efficacy of Fructose Metabolizing Enzymatic Product in Fructose Malabsorption
Lead Sponsor:
Sciotec Diagnostic Technologies GmbH
Collaborating Sponsors:
Austrian Research Promotion Agency
Conditions:
Fructose Malabsorption
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether the enzymatic product Frucosin(R) is able to degrade fructose in vivo in the small intestine of patients with known fructose malabsorption by measurin...
Detailed Description
Fructose malabsorption is a digestive disorder in which the uptake of fructose in the small intestine is deficient. This leads to an increase of the concentration of fructose in the large intestine af...
Eligibility Criteria
Inclusion
- diagnosed fructose malabsorption
Exclusion
- Gravidity
- diabetes mellitus
- recent gastrointestinal surgery
- recent endoscopy
- recent antibiotics therapy
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00916487
Start Date
June 1 2009
End Date
August 1 2010
Last Update
December 20 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz
Graz, Styria, Austria, A-8036